Uzair Abbas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Uzair Abbas has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
Niaz Hussain
14 shared publicationsMuhib Ullah Khalid
Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan
9 shared publicationsMahtab Khan
Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan
6 shared publicationsIshfaque Ahmed
Sindh Infectious Diseases Hospital and Research Center, Dow University of Health Sciences, Karachi, Pakistan
5 shared publicationsUsama Abdul Musawwir
Department of Physiology, Dow University of Health Sciences, Karachi, Pakistan
5 shared publicationsRabeel Nawaz Laghari
Department of Medicine, Indus Medical College Hospital, Tando Muhammad Khan, Pakistan
4 shared publications
Latest Publications
- Open Access
- 8 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16  (1)
Electrodermal activity response to smartphone deprivation: a physiology laboratory-based study of nomophobia in undergraduate dental students
- 8 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16  (1)
Open AccessElectrodermal activity response to smartphone deprivation: a physiology laboratory-based study of nomophobia in undergraduate dental students
- Open Access
- 6 July 2026
- Published by Springer Nature in Discover Mental Health
- Vol. 6  (1)
Elevated cortisol in patients with type 2 diabetes mellitus and comorbid depressive symptoms is associated with poor glycemic control and reduced insulin levels
Diabetes and depression are highly prevalent chronic conditions, and their comorbidity further impacts quality of life and disease outcomes. Cortisol, the primary stress hormone and a diabetogenic hormone, plays a potential role in linking these conditions. Chronic stress may lead to persistently elevated cortisol levels, which may influence metabolic activity and glycemic control. This study aimed to determine the prevalence and severity of depressive symptoms among patients with type 2 diabetes and to evaluate the association of cortisol levels with depressive symptom severity and glycemic control. In this case-control study, we recruited 100 individuals without diabetes and 200 diagnosed patients with type 2 diabetes. Participants were screened for clinically significant depressive and anxiety symptoms using the Hamilton Depression Rating Scale (HAM-D) and Hamilton Anxiety Rating Scale (HAM-A), respectively. Morning cortisol levels were measured, and their associations with depressive symptom severity and glycemic control were evaluated in patients with type 2 diabetes. The prevalence of clinically significant depressive symptoms was higher in patients with type 2 diabetes compared to individuals without diabetes (38% vs. 13%, p < 0.001). Similarly, clinically significant anxiety symptoms were more frequent in patients with type 2 diabetes (14.5% vs. 9%, p = 0.03). Mean cortisol levels were significantly higher in patients with type 2 diabetes (p < 0.001). Among patients with type 2 diabetes, those with severe depressive symptoms had higher cortisol and HbA1c levels and lower insulin levels (p < 0.05). Longer diabetes duration and exclusive insulin therapy were associated with less favorable metabolic profiles. Independent predictors of hypercortisolism included moderate-to-severe depressive symptoms, elevated HbA1c, longer disease duration, insulin therapy, and diabetic complications. In patients with type 2 diabetes and comorbid depressive symptoms, higher cortisol levels were associated with poorer glycemic control and lower insulin levels, particularly in those with severe depressive symptoms. These findings support the importance of incorporating mental health screening into diabetes care for better disease management.
- 6 July 2026
- Published by Springer Nature in Discover Mental Health
- Vol. 6  (1)
Open AccessElevated cortisol in patients with type 2 diabetes mellitus and comorbid depressive symptoms is associated with poor glycemic control and reduced insulin levels
Diabetes and depression are highly prevalent chronic conditions, and their comorbidity further impacts quality of life and disease outcomes. Cortisol, the primary stress hormone and a diabetogenic hormone, plays a potential role in linking these conditions. Chronic stress may lead to persistently elevated cortisol levels, which may influence metabolic activity and glycemic control. This study aimed to determine the prevalence and severity of depressive symptoms among patients with type 2 diabetes and to evaluate the association of cortisol levels with depressive symptom severity and glycemic control. In this case-control study, we recruited 100 individuals without diabetes and 200 diagnosed patients with type 2 diabetes. Participants were screened for clinically significant depressive and anxiety symptoms using the Hamilton Depression Rating Scale (HAM-D) and Hamilton Anxiety Rating Scale (HAM-A), respectively. Morning cortisol levels were measured, and their associations with depressive symptom severity and glycemic control were evaluated in patients with type 2 diabetes. The prevalence of clinically significant depressive symptoms was higher in patients with type 2 diabetes compared to individuals without diabetes (38% vs. 13%, p < 0.001). Similarly, clinically significant anxiety symptoms were more frequent in patients with type 2 diabetes (14.5% vs. 9%, p = 0.03). Mean cortisol levels were significantly higher in patients with type 2 diabetes (p < 0.001). Among patients with type 2 diabetes, those with severe depressive symptoms had higher cortisol and HbA1c levels and lower insulin levels (p < 0.05). Longer diabetes duration and exclusive insulin therapy were associated with less favorable metabolic profiles. Independent predictors of hypercortisolism included moderate-to-severe depressive symptoms, elevated HbA1c, longer disease duration, insulin therapy, and diabetic complications. In patients with type 2 diabetes and comorbid depressive symptoms, higher cortisol levels were associated with poorer glycemic control and lower insulin levels, particularly in those with severe depressive symptoms. These findings support the importance of incorporating mental health screening into diabetes care for better disease management.
- Open Access
- 21 June 2026
- Published by Springer Nature in Discover Artificial Intelligence
- Vol. 6  (1)
Opportunities and challenges of integrating artificial intelligence into undergraduate medical education in low-and middle-income countries
- 21 June 2026
- Published by Springer Nature in Discover Artificial Intelligence
- Vol. 6  (1)
Open AccessOpportunities and challenges of integrating artificial intelligence into undergraduate medical education in low-and middle-income countries
- Open Access
- 15 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16  (1)
Integrated immune, apoptotic and mitochondrial gene dysregulation in Long COVID and their association with symptom burden at 10 months post-infection
Long COVID is characterized by persistent symptoms following acute SARS-CoV-2 infection, yet its biological mechanisms remain incompletely understood. Emerging evidence suggests that immune dysregulation, mitochondrial dysfunction, and altered cell survival pathways may contribute to prolonged symptomatology. In this cross-sectional study, peripheral blood mononuclear cells were collected from individuals with Long COVID approximately 10 months post-infection and from recovered individuals without Long COVID symptoms. Symptom burden was assessed using a composite domain-based score. mRNA expression of immune and antiviral genes (IL-6, IL-1β, IL-10, SOCS3, HIF-1α, OAS1, MAVS, IFN-α, IFN-γ), anti-apoptotic markers (MCL1, BCL-2, XIAP, LIVIN), cell cycle kinases (CDK4, CDK6), mitochondrial biogenesis and dynamics markers (NRF1, TFAM, PGC-1α, DRP1, MFN1/2, OPA1), and mitophagy regulators (PARKIN, PINK1) were quantified using quantitative real-time PCR. Data was analyzed by SPSS and GraphPad Prism. Individuals with Long COVID demonstrated significantly higher expressions of IL-6, IL-1β, IL-10, SOCS3, HIF-1α, OAS1, MAVS, NRF1, DRP1, PARKIN, MCL1, and LIVIN compared with recovered controls after using the Benjamini–Hochberg False Discovery Rate (FDR) method. Several transcriptional markers, particularly HIF-1α, IL-1β, IL-10, and NRF1, remained independently associated with symptom burden after adjustment for age and sex. Correlation analysis demonstrated coordinated transcriptional co-expression patterns across immune, antiviral, mitochondrial, and apoptosis-related genes. Long COVID at 10 months post-infection is associated with coordinated transcriptional alterations across multiple biological pathways. The association of these changes with symptom burden suggests a potential link between persistent immunometabolic activation and clinical manifestations. These findings are exploratory and highlight the need for longitudinal and functional studies to further elucidate underlying mechanisms.
- 15 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16  (1)
Open AccessIntegrated immune, apoptotic and mitochondrial gene dysregulation in Long COVID and their association with symptom burden at 10 months post-infection
Long COVID is characterized by persistent symptoms following acute SARS-CoV-2 infection, yet its biological mechanisms remain incompletely understood. Emerging evidence suggests that immune dysregulation, mitochondrial dysfunction, and altered cell survival pathways may contribute to prolonged symptomatology. In this cross-sectional study, peripheral blood mononuclear cells were collected from individuals with Long COVID approximately 10 months post-infection and from recovered individuals without Long COVID symptoms. Symptom burden was assessed using a composite domain-based score. mRNA expression of immune and antiviral genes (IL-6, IL-1β, IL-10, SOCS3, HIF-1α, OAS1, MAVS, IFN-α, IFN-γ), anti-apoptotic markers (MCL1, BCL-2, XIAP, LIVIN), cell cycle kinases (CDK4, CDK6), mitochondrial biogenesis and dynamics markers (NRF1, TFAM, PGC-1α, DRP1, MFN1/2, OPA1), and mitophagy regulators (PARKIN, PINK1) were quantified using quantitative real-time PCR. Data was analyzed by SPSS and GraphPad Prism. Individuals with Long COVID demonstrated significantly higher expressions of IL-6, IL-1β, IL-10, SOCS3, HIF-1α, OAS1, MAVS, NRF1, DRP1, PARKIN, MCL1, and LIVIN compared with recovered controls after using the Benjamini–Hochberg False Discovery Rate (FDR) method. Several transcriptional markers, particularly HIF-1α, IL-1β, IL-10, and NRF1, remained independently associated with symptom burden after adjustment for age and sex. Correlation analysis demonstrated coordinated transcriptional co-expression patterns across immune, antiviral, mitochondrial, and apoptosis-related genes. Long COVID at 10 months post-infection is associated with coordinated transcriptional alterations across multiple biological pathways. The association of these changes with symptom burden suggests a potential link between persistent immunometabolic activation and clinical manifestations. These findings are exploratory and highlight the need for longitudinal and functional studies to further elucidate underlying mechanisms.
- Open Access
- 15 April 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21  (4) , e0346978
Acute SARS-CoV-2 viral load and systemic inflammation are associated with neuropsychiatric and musculoskeletal symptoms in long COVID
Background: Long after recovery from acute-COVID illness, many patients show persistent multi-organ dysfunction consistent with Long COVID. Biochemical profile and measurements of inflammatory markers in these individuals can help to understand the underlying pathophysiology. This study aims to evaluate biochemical markers and their association with symptoms of Long COVID. We, in a retrospective analysis, also examined whether the Long COVID symptom persistence is associated with the SARS-CoV-2 viral load documented during the acute infection. Methods: A total of 300 participants with previously diagnosed mild COVID-19 were recruited at 10 months post-infection. Brief clinical history was taken based on persistent symptoms after COVID-19 and categorized as Long COVID (n = 177) and controls group (n = 123) based on WHO defined criteria. Biochemical parameters in blood like complete blood count (RBC and WBC indices) were compared between the groups. Other measurements including inflammatory markers such as IL-6, IL-10, ferritin and C-reactive protein along with electrolytes, vitamin D3 and B12, and lipid profile, were also compared. SARS-CoV-2 viral load was assessed retrospectively. Data was analyzed through SPSS v.26. Results: The findings of our study revealed that 59% (177) of individuals had symptoms of Long COVID. The most frequently reported symptoms of Long COVID were related to neuropsychiatry (35%), followed by musculoskeletal system (32.2%). The Hemoglobin, RBC counts and MCHC were decreased in Long COVID as compared to control group (p < 0.05). While Lymphocytes, IL-6 and ferritin levels were raised in Long COVID group (p < 0.05). In multivariable logistic regression analyses adjusted for age and sex, neuropsychiatric symptoms were independently associated with higher lymphocyte counts (aOR 1.19, 95% CI 1.12–1.51), IL-6 (aOR 1.16, 95% CI 1.10–1.86), ferritin (aOR 1.42, 95% CI 1.10–1.53), and vitamin D deficiency (aOR 1.45, 95% CI 1.22–2.01). Musculoskeletal symptoms were strongly associated with vitamin D deficiency (aOR 2.30, 95% CI 1.20–4.50) and ferritin levels (aOR 0.98, 95% CI 0.97–0.99). Moreover, higher SARS-CoV-2 viral load (CT ≤ 20) during acute infection was also associated with neuropsychiatric and musculoskeletal symptoms of Long COVID. Conclusion: We identified Long COVID in 59% of the participants, the highest reported percentage in studies in the middle-aged individuals. Compared to controls, we found differential biochemical markers in the Long COVID group indicating a different metabolic status in these individuals. Moreover, the association of raised inflammatory markers at ten months follow up and acute-phase SARS-CoV-2 viral load were also seen to be associated with musculoskeletal and neuropsychiatric symptoms of the Long COVID. These significant clinical and biochemical changes warrant thorough monitoring and follow-ups for extended time.
- 15 April 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21  (4) , e0346978
Open AccessAcute SARS-CoV-2 viral load and systemic inflammation are associated with neuropsychiatric and musculoskeletal symptoms in long COVID
Background: Long after recovery from acute-COVID illness, many patients show persistent multi-organ dysfunction consistent with Long COVID. Biochemical profile and measurements of inflammatory markers in these individuals can help to understand the underlying pathophysiology. This study aims to evaluate biochemical markers and their association with symptoms of Long COVID. We, in a retrospective analysis, also examined whether the Long COVID symptom persistence is associated with the SARS-CoV-2 viral load documented during the acute infection. Methods: A total of 300 participants with previously diagnosed mild COVID-19 were recruited at 10 months post-infection. Brief clinical history was taken based on persistent symptoms after COVID-19 and categorized as Long COVID (n = 177) and controls group (n = 123) based on WHO defined criteria. Biochemical parameters in blood like complete blood count (RBC and WBC indices) were compared between the groups. Other measurements including inflammatory markers such as IL-6, IL-10, ferritin and C-reactive protein along with electrolytes, vitamin D3 and B12, and lipid profile, were also compared. SARS-CoV-2 viral load was assessed retrospectively. Data was analyzed through SPSS v.26. Results: The findings of our study revealed that 59% (177) of individuals had symptoms of Long COVID. The most frequently reported symptoms of Long COVID were related to neuropsychiatry (35%), followed by musculoskeletal system (32.2%). The Hemoglobin, RBC counts and MCHC were decreased in Long COVID as compared to control group (p < 0.05). While Lymphocytes, IL-6 and ferritin levels were raised in Long COVID group (p < 0.05). In multivariable logistic regression analyses adjusted for age and sex, neuropsychiatric symptoms were independently associated with higher lymphocyte counts (aOR 1.19, 95% CI 1.12–1.51), IL-6 (aOR 1.16, 95% CI 1.10–1.86), ferritin (aOR 1.42, 95% CI 1.10–1.53), and vitamin D deficiency (aOR 1.45, 95% CI 1.22–2.01). Musculoskeletal symptoms were strongly associated with vitamin D deficiency (aOR 2.30, 95% CI 1.20–4.50) and ferritin levels (aOR 0.98, 95% CI 0.97–0.99). Moreover, higher SARS-CoV-2 viral load (CT ≤ 20) during acute infection was also associated with neuropsychiatric and musculoskeletal symptoms of Long COVID. Conclusion: We identified Long COVID in 59% of the participants, the highest reported percentage in studies in the middle-aged individuals. Compared to controls, we found differential biochemical markers in the Long COVID group indicating a different metabolic status in these individuals. Moreover, the association of raised inflammatory markers at ten months follow up and acute-phase SARS-CoV-2 viral load were also seen to be associated with musculoskeletal and neuropsychiatric symptoms of the Long COVID. These significant clinical and biochemical changes warrant thorough monitoring and follow-ups for extended time.
- Open Access
- 26 March 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26  (1)
Impact of peer assessment on lecture quality and student learning outcomes in undergraduate medical education: a quasi-experimental study
Peer review of teaching has been recognized to enhance teaching effectiveness and faculty development, but its impact on lecture quality and student learning outcomes remains unclear. While many institutions rely on student evaluations, evidence on whether peer assessment improves both teaching and learning is limited. This study was designed to examine the effect of peer assessment on lecture quality and student learning outcomes among undergraduate medical students. This quasi-experimental study with mixed method approach included faculty (n = 10) and students (n = 120). The intervention group received peer feedback along with standard student evaluations and the control group received standard student evaluations only. The lecture quality was assessed through 5-point Likert scale as well as open ended group discussions as to make quantitative and qualitative assessments respectively. Student’s performance was also checked before and after the lecture related to the topic taught. Peer review was associated with higher lecture quality ratings after the intervention, with students reporting significant improvements in organization, clarity, and engagement (p < 0.01). At baseline, peer reviewers rated lectures more critically than students; however, this difference reduced following revision. Students in the intervention group demonstrated greater gains in post-lecture knowledge assessments compared with the control group (p < 0.05). Post-intervention qualitative findings from students and peers highlighted better structure, increased interaction, and visible incorporation of feedback. Conversely, students whose lecturers did not undergo peer review continued to report ineffective teaching and minimal responsiveness to feedback. Structured peer review may contribute to improvements in lecture quality, faculty teaching effectiveness, and student learning outcomes. Integrating peer assessment alongside traditional student evaluations can strengthen faculty development and improve knowledge retention in undergraduate medical education. Further studies are required to confirm sustainability and generalizability across medical schools in different settings. The online version contains supplementary material available at 10.1186/s12909-026-09042-9.
- 26 March 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26  (1)
Open AccessImpact of peer assessment on lecture quality and student learning outcomes in undergraduate medical education: a quasi-experimental study
Peer review of teaching has been recognized to enhance teaching effectiveness and faculty development, but its impact on lecture quality and student learning outcomes remains unclear. While many institutions rely on student evaluations, evidence on whether peer assessment improves both teaching and learning is limited. This study was designed to examine the effect of peer assessment on lecture quality and student learning outcomes among undergraduate medical students. This quasi-experimental study with mixed method approach included faculty (n = 10) and students (n = 120). The intervention group received peer feedback along with standard student evaluations and the control group received standard student evaluations only. The lecture quality was assessed through 5-point Likert scale as well as open ended group discussions as to make quantitative and qualitative assessments respectively. Student’s performance was also checked before and after the lecture related to the topic taught. Peer review was associated with higher lecture quality ratings after the intervention, with students reporting significant improvements in organization, clarity, and engagement (p < 0.01). At baseline, peer reviewers rated lectures more critically than students; however, this difference reduced following revision. Students in the intervention group demonstrated greater gains in post-lecture knowledge assessments compared with the control group (p < 0.05). Post-intervention qualitative findings from students and peers highlighted better structure, increased interaction, and visible incorporation of feedback. Conversely, students whose lecturers did not undergo peer review continued to report ineffective teaching and minimal responsiveness to feedback. Structured peer review may contribute to improvements in lecture quality, faculty teaching effectiveness, and student learning outcomes. Integrating peer assessment alongside traditional student evaluations can strengthen faculty development and improve knowledge retention in undergraduate medical education. Further studies are required to confirm sustainability and generalizability across medical schools in different settings. The online version contains supplementary material available at 10.1186/s12909-026-09042-9.
- Open Access
- 22 February 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16  (1)
Undergraduate medical students’ perceptions of case-based learning in preclinical physiology within a resource limited setting: a qualitative study
Case-based learning (CBL) is widely promoted in medical education to enhance engagement, conceptual understanding, and early clinical reasoning. However, most evidence supporting its effectiveness originates from well-resourced institutions, and their feasibility and impact within resource-limited preclinical settings remain uncertain, where large class sizes, limited infrastructure, and reliance on didactic teaching persist. This qualitative descriptive study explored undergraduate medical students’ perceptions of CBL implementation in preclinical physiology at a public-sector medical university. Four focus group discussions were conducted with 30 second-year Bachelor of Medicine, Bachelor of Surgery (MBBS) students. Data was audio-recorded, transcribed verbatim, and analyzed using reflexive thematic analysis following Braun and Clarke’s framework. Students valued CBL for promoting active participation, improved conceptual clarity, knowledge retention, and early development of clinical reasoning. However, its effectiveness was moderated by contextual constraints, including limited time, inconsistent facilitation, restricted clinical exposure, and lack of visual learning resources. Participants proposed feasible adaptations such as simplified case design, phased progression of complexity, standardized facilitation, and incorporation of low-cost multimedia aids. These findings suggest that while CBL is pedagogically valuable, successful implementation in resource-limited preclinical environments requires deliberate contextual adaptation rather than direct adoption of models developed in high-resource settings.
- 22 February 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16  (1)
Open AccessUndergraduate medical students’ perceptions of case-based learning in preclinical physiology within a resource limited setting: a qualitative study
Case-based learning (CBL) is widely promoted in medical education to enhance engagement, conceptual understanding, and early clinical reasoning. However, most evidence supporting its effectiveness originates from well-resourced institutions, and their feasibility and impact within resource-limited preclinical settings remain uncertain, where large class sizes, limited infrastructure, and reliance on didactic teaching persist. This qualitative descriptive study explored undergraduate medical students’ perceptions of CBL implementation in preclinical physiology at a public-sector medical university. Four focus group discussions were conducted with 30 second-year Bachelor of Medicine, Bachelor of Surgery (MBBS) students. Data was audio-recorded, transcribed verbatim, and analyzed using reflexive thematic analysis following Braun and Clarke’s framework. Students valued CBL for promoting active participation, improved conceptual clarity, knowledge retention, and early development of clinical reasoning. However, its effectiveness was moderated by contextual constraints, including limited time, inconsistent facilitation, restricted clinical exposure, and lack of visual learning resources. Participants proposed feasible adaptations such as simplified case design, phased progression of complexity, standardized facilitation, and incorporation of low-cost multimedia aids. These findings suggest that while CBL is pedagogically valuable, successful implementation in resource-limited preclinical environments requires deliberate contextual adaptation rather than direct adoption of models developed in high-resource settings.
- Open Access
- 30 December 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20  (12) , e0339240
Individuals with latent tuberculosis in a high TB endemic country show mild COVID-19
Introduction: Infection with Mycobacterium tuberculosis (MTB) may result in active tuberculosis (TB), bacterial clearance, or asymptomatic latent infection (LTBi). During the COVID-19 pandemic, interactions between MTB and SARS-CoV-2 infections were coincident in high TB burden countries such as Pakistan. The impact of LTBi on COVID-19 is not well understood. Here we investigated the association of LTBi with COVID-19 and its severity by determining cellular activation to MTB, IgG antibody responses and expression of genes associated with host immunity. Methods: Age and sex matched Healthy Controls (HC, n = 147) and COVID-19 patients (n = 128) were recruited in this cross-sectional study. COVID-19 was categorized as ambulatory (n = 103) or hospitalized (n = 25) disease. LTBi was determined using the X.DOT-TB ELISpot assay. RT-PCR based mRNA levels of IFN-γ, IFN-α, IL-6, IL-10, OAS1, MAVS, SOCS1 and SOCS3 were determined in PBMCs. IgG to SARS-CoV-2 and rubella virus were measured. Results: We found that 18% of COVID-19 patients and 32% of HC were LTBi positive (p < 0.0001). All COVID-19 LTBi positive cases had ambulatory disease. Logistic regression analysis revealed individuals with LTBi to have a 54% lower risk of COVID-19. The frequency of MTB-specific IFN-γ producing T cells was lower in COVID-19 patients than in HC LTBi positive individuals (p = 0.0095). The presence of a BCG scar was not associated with the occurrence of COVID-19. Levels of IgG antibodies to SARS-CoV-2 were raised in COVID-19 cases but did not differ by LTBi status in HC or COVID-19 groups. IgG levels to rubella virus were similar regardless of LTBi status in control and patient groups. COVID-19 cases displayed higher expression of mRNA levels of MAVS, OAS-1, and SOCS3 (p < 0.05). Further, OAS-1 expression was raised in LTBi positive COVID-19 group as compared to the LTBi positive HC group (p = 0.019). Conclusions: We observed that T cell reactivity to MTB was associated with milder COVID-19. Reduced severity of COVID-19 and higher OAS-1 gene expression in COVID-19 LTBi positive individuals suggest a protective effect in these individuals. Further studies are required to investigate the combined impact of MTB and SARS-CoV-2 infections in the host.
- 30 December 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20  (12) , e0339240
Open AccessIndividuals with latent tuberculosis in a high TB endemic country show mild COVID-19
Introduction: Infection with Mycobacterium tuberculosis (MTB) may result in active tuberculosis (TB), bacterial clearance, or asymptomatic latent infection (LTBi). During the COVID-19 pandemic, interactions between MTB and SARS-CoV-2 infections were coincident in high TB burden countries such as Pakistan. The impact of LTBi on COVID-19 is not well understood. Here we investigated the association of LTBi with COVID-19 and its severity by determining cellular activation to MTB, IgG antibody responses and expression of genes associated with host immunity. Methods: Age and sex matched Healthy Controls (HC, n = 147) and COVID-19 patients (n = 128) were recruited in this cross-sectional study. COVID-19 was categorized as ambulatory (n = 103) or hospitalized (n = 25) disease. LTBi was determined using the X.DOT-TB ELISpot assay. RT-PCR based mRNA levels of IFN-γ, IFN-α, IL-6, IL-10, OAS1, MAVS, SOCS1 and SOCS3 were determined in PBMCs. IgG to SARS-CoV-2 and rubella virus were measured. Results: We found that 18% of COVID-19 patients and 32% of HC were LTBi positive (p < 0.0001). All COVID-19 LTBi positive cases had ambulatory disease. Logistic regression analysis revealed individuals with LTBi to have a 54% lower risk of COVID-19. The frequency of MTB-specific IFN-γ producing T cells was lower in COVID-19 patients than in HC LTBi positive individuals (p = 0.0095). The presence of a BCG scar was not associated with the occurrence of COVID-19. Levels of IgG antibodies to SARS-CoV-2 were raised in COVID-19 cases but did not differ by LTBi status in HC or COVID-19 groups. IgG levels to rubella virus were similar regardless of LTBi status in control and patient groups. COVID-19 cases displayed higher expression of mRNA levels of MAVS, OAS-1, and SOCS3 (p < 0.05). Further, OAS-1 expression was raised in LTBi positive COVID-19 group as compared to the LTBi positive HC group (p = 0.019). Conclusions: We observed that T cell reactivity to MTB was associated with milder COVID-19. Reduced severity of COVID-19 and higher OAS-1 gene expression in COVID-19 LTBi positive individuals suggest a protective effect in these individuals. Further studies are required to investigate the combined impact of MTB and SARS-CoV-2 infections in the host.
- Open Access
- 12 December 2025
- Published by Springer Nature in BMC Medical Education
- Vol. 26  (1)
Evaluation of a medical school’s mentorship program using CIPP model: a mixed-methods study
Mentoring medical students has become a prevalent educational strategy in medical schools with the purpose of their professional development. For
- 12 December 2025
- Published by Springer Nature in BMC Medical Education
- Vol. 26  (1)
Open AccessEvaluation of a medical school’s mentorship program using CIPP model: a mixed-methods study
Mentoring medical students has become a prevalent educational strategy in medical schools with the purpose of their professional development. For
- Open Access
- 3 December 2025
- Published by Elsevier in Tuberculosis
- Vol. 156, 102718
Dysregulated IFN-γ, IL-6 and TNF-α after COVID-19 is suggestive of lowered innate immune responses to SARS-CoV-2 and MTB
- 3 December 2025
- Published by Elsevier in Tuberculosis
- Vol. 156, 102718
Open AccessDysregulated IFN-γ, IL-6 and TNF-α after COVID-19 is suggestive of lowered innate immune responses to SARS-CoV-2 and MTB